Brintellix and abilify

Vortioxetine and Aripiprazole Combination in Treatment-Resistant Obsessive-Compulsive Disorder: A Case Report

Case Reports

. 2017 Dec;37(6):732-734.

doi: 10.1097/JCP.0000000000000801.

Domenico De Berardis  1 , Luigi Olivieri, Francesco Nappi, Gabriella Rapini, Federica Vellante, Ilaria Matarazzo, Nicola Serroni, Massimo Di Giannantonio



  • 1 NHS, Department of Mental Health Psychiatric Service of Diagnosis and Treatment Hospital "G. Mazzini," ASL 4 Teramo, Italy and Department of Neurosciences and Imaging Chair of Psychiatry University "G. d'Annunzio," Chieti, Italy [email protected] NHS, Department of Mental Health Psychiatric Service of Diagnosis and Treatment Hospital "G. Mazzini," ASL 4 Teramo, Italy NHS, Department of Mental Health Psychiatric Service of Diagnosis and Treatment Hospital "G. Mazzini," ASL 4 Teramo, Italy and Department of Neurosciences and Imaging Chair of Psychiatry University "G. d'Annunzio," Chieti, Italy NHS, Department of Mental Health Psychiatric Service of Diagnosis and Treatment Hospital "G. Mazzini," ASL 4 Teramo, Italy Department of Neurosciences and Imaging Chair of Psychiatry University "G. d'Annunzio," Chieti, Italy.
  • PMID: 29040153
  • DOI: 10.1097/JCP.0000000000000801

Case Reports

Domenico De Berardis et al. J Clin Psychopharmacol. 2017 Dec.

. 2017 Dec;37(6):732-734.

doi: 10.1097/JCP.0000000000000801.


Domenico De Berardis  1 , Luigi Olivieri, Francesco Nappi, Gabriella Rapini, Federica Vellante, Ilaria Matarazzo, Nicola Serroni, Massimo Di Giannantonio


  • 1 NHS, Department of Mental Health Psychiatric Service of Diagnosis and Treatment Hospital "G. Mazzini," ASL 4 Teramo, Italy and Department of Neurosciences and Imaging Chair of Psychiatry University "G. d'Annunzio," Chieti, Italy [email protected] NHS, Department of Mental Health Psychiatric Service of Diagnosis and Treatment Hospital "G. Mazzini," ASL 4 Teramo, Italy NHS, Department of Mental Health Psychiatric Service of Diagnosis and Treatment Hospital "G. Mazzini," ASL 4 Teramo, Italy and Department of Neurosciences and Imaging Chair of Psychiatry University "G. d'Annunzio," Chieti, Italy NHS, Department of Mental Health Psychiatric Service of Diagnosis and Treatment Hospital "G. Mazzini," ASL 4 Teramo, Italy Department of Neurosciences and Imaging Chair of Psychiatry University "G. d'Annunzio," Chieti, Italy.
  • PMID: 29040153
  • DOI: 10.1097/JCP.0000000000000801

No abstract available

Similar articles

  • Aripiprazole augmentation in highly treatment-resistant obsessive-compulsive disorder - experience from a specialty clinic in India.

    Hegde A, Kalyani BG, Arumugham SS, Narayanaswamy JC, Math SB, Reddy YC. Hegde A, et al. Int J Psychiatry Clin Pract. 2017 Mar;21(1):67-69. doi: 10.1080/13651501.2016.1225098. Epub 2016 Sep 14. Int J Psychiatry Clin Pract. 2017. PMID: 27629160

  • Treat the disease not the symptoms: Successful management of obsessive compulsive disorder in bipolar disorder with aripiprazole augmentation.

    Patra S. Patra S. Aust N Z J Psychiatry. 2016 Aug;50(8):809-10. doi: 10.1177/0004867416656262. Epub 2016 Jun 29. Aust N Z J Psychiatry. 2016. PMID: 27357710 No abstract available.

  • Aripiprazole Monotherapy Was Effective in Treating Obsessive-Compulsive Disorder in a Preschool Boy.

    Coskun M. Coskun M. J Clin Psychopharmacol. 2017 Oct;37(5):636-637. doi: 10.1097/JCP.0000000000000748. J Clin Psychopharmacol. 2017. PMID: 28786825 No abstract available.

  • Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials.

    Dold M, Aigner M, Lanzenberger R, Kasper S. Dold M, et al. Int J Neuropsychopharmacol. 2013 Apr;16(3):557-74. doi: 10.1017/S1461145712000740. Epub 2012 Aug 29. Int J Neuropsychopharmacol. 2013. PMID: 22932229 Review.

  • A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.

    Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. Bloch MH, et al. Mol Psychiatry. 2006 Jul;11(7):622-32. doi: 10.1038/ Epub 2006 Apr 4. Mol Psychiatry. 2006. PMID: 16585942 Review.

See all similar articles

Cited by

  • Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study.

    De Berardis D, Fornaro M, Anastasia A, Vellante F, Olivieri L, Rapini G, Serroni N, Orsolini L, Valchera A, Carano A, Tomasetti C, Ventriglio A, Bustini M, Pompili M, Serafini G, Perna G, Iasevoli F, Martinotti G, Di Giannantonio M. De Berardis D, et al. Braz J Psychiatry. 2020;42(3):317-321. doi: 10.1590/1516-4446-2019-0690. Epub 2020 Mar 9. Braz J Psychiatry. 2020. PMID: 32159712 Free PMC article.

  • Vortioxetine treatment for generalised anxiety disorder: a meta-analysis of anxiety, quality of life and safety outcomes.

    Qin B, Huang G, Yang Q, Zhao M, Chen H, Gao W, Yang M. Qin B, et al. BMJ Open. 2019 Nov 28;9(11):e033161. doi: 10.1136/bmjopen-2019-033161. BMJ Open. 2019. PMID: 31784448 Free PMC article.

Publication types

MeSH terms


What Antidepressants Work Best with Abilify? I Psych Central

Antidepressants alone may not be enough for adults with major depressive disorder. Aripiprazole (Abilify) can be taken alongside antidepressants to treat symptoms of depression.

Antidepressants are some of the most prescribed drugs for treating anxiety and depression combined.

During 2015 to 2018, an estimated 13.2% of U.S. adults used antidepressant medications in the past 30 days, according to the Centers for Disease Control and Prevention (CDC).

Antidepressants have been shown to be effective against depression and anxiety, but antidepressants alone may not be enough for some people.

Depression symptoms that return while taking antidepressants is known as breakthrough depression. It occurs in 33% of people using antidepressants.

Taking other medications, such as Abilify, alongside your antidepressants as part of your treatment may help improve your symptoms.

Abilify is a brand-name medication of the prescription drug aripiprazole. It’s an atypical antipsychotic drug, according to the Food and Drug Administration (FDA).

Atypical antipsychotics are second-generation antipsychotics. Some work by blocking the action of dopamine on the receptors of specific neurons in the brain.

Second-generation antipsychotics may have fewer side effects than first-generation drugs. Second-generation antipsychotics’ effect on 5-HT-2a receptors may be linked to lower neurological side effects.

The FDA has approved Abilify as an adjunctive treatment for adults with major depressive disorder (MDD) without psychotic symptoms and when antidepressants alone aren’t enough.

Abilify is often used alongside antidepressants. This is why it’s usually included as part of augmentation therapy, when drugs are combined. It’s not approved for this use among children.

The main active drug in Abilify, aripiprazole, is used to treat schizophrenia, according to the National Alliance of Mental Illness (NAMI). It’s also FDA-approved to treat symptoms of:

  • bipolar disorder
  • Tourette syndrome
  • autism spectrum disorder (ASD)

There are different forms of Abilify, but it’s usually taken orally in the form of tablets that are swallowed whole. Abilify can usually be taken with or without food.

Abilify works by regulating the action that neurotransmitters have on the brain.

It’s mainly known as a modulator of dopamine. It can act as a partial agonist to dopamine receptors when dopamine activity is high. It also helps balance dopamine when activity levels are low.

Similar to its effects on dopamine receptors, Abilify is a partial agonist to serotonin receptors.

Abilify can work alone for other disorders, but for depression, it’s most effective as an add-on treatment or part of augmentation therapy.

Antidepressants are the main treatment for depression, but only one-third of patients will reach remission with their initial treatment, according to 2008 research. The other two-thirds are likely to fail to reach remission, and they must continue their search for an effective treatment plan.

Adding Abilify to an existing treatment plan can have positive outcomes compared to monotherapy, or treating depression with one medication at a time.

Aripiprazole was found to increase the effectiveness of mirtazapine, an antidepressant drug, compared to mirtazapine monotherapy, according to a 2007 study. Researchers believe it may be especially effective in patients with treatment-resistant depression.

Adjunctive aripiprazole was associated with a two-fold higher remission rate than adjunctive placebo. It was also found to be relatively well-tolerated and safe, according to a 2009 clinical trial.

When people with depression don’t reach remission with one treatment, they may switch to another antidepressant drug.

A 2017 study found that augmenting with aripiprazole was more effective than switching to another antidepressant. Among patients with major depressive disorder unresponsive to previous treatment, 29% achieved remission after augmenting with aripiprazole.

Abilify is usually taken alongside other antidepressants in people with depression.

Antidepressants include selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs).

Common antidepressants include:

  • fluoxetine (Prozac)
  • sertraline (Zoloft)
  • escitalopram (Lexapro)
  • paroxetine (Paxil)
  • citalopram (Celexa)
  • fluvoxamine (Luvox)
  • vilazodone (Viibryd)
  • duloxetine (Cymbalta)
  • venlafaxine (Effexor)
  • desvenlafaxine (Pristiq)
  • levomilnacipran (Fetzima)

Note that Abilify may interact with other drugs. A doctor will be able to advise about medication interactions before you decide to take Abilify.

There’s limited research on the effectiveness of aripiprazole when combined with specific antidepressants. But some studies found that Abilify and Lexapro can be an effective treatment for depression.

When combined with escitalopram (Lexapro), Abilify was found to be an effective and safe treatment for major depressive disorder, according to a 2009 study.

Many drugs interact with aripiprazole, which can lead to severe complications.

Abilify may interact with the following drugs:

  • metoclopramide
  • Adderall
  • clarithromycin
  • itraconazole
  • quinidine
  • Prozac
  • Paxil
  • carbamazepine
  • rifampin
  • lorazepam

This isn’t an exhaustive list of possible drug interactions with Abilify. If you take any medications, you’ll want to tell your doctor and pharmacist before taking Abilify.

Before starting any new medication, you’ll want to ask your doctor for more information. Antipsychotics are known for having many side effects. Abilify has many known drug interactions.

Here are some questions you can ask the doctor before taking Abilify alongside antidepressants:

  • Does Abilify interact with any medications I’m currently taking?
  • Should Abilify be taken with food or on an empty stomach?
  • How long until I see results with Abilify?
  • What are the short-term side effects of Abilify?
  • What are the long-term side effects of Abilify?
  • Is it safe to drink alcohol while taking Abilify?
  • How and when should I take Abilify?
  • When do I stop taking Abilify?
  • What foods or drinks should I avoid while taking Abilify?
  • How do you monitor Abilify?
  • How will we know if the dose needs to be changed?
  • What should I do if I miss a dose?

Dealing with depression isn’t easy, and you’re not alone.

An estimated 5% of people worldwide have depression. Different treatment options exist for those with depression, but treatment effectiveness can vary from person to person.

If your antidepressants have stopped working, combining them with Abilify may provide some relief.

Abilify is a prescription drug for patients with schizophrenia, but it can also help alleviate symptoms of other mental health disorders, including major depressive disorder.

Talk with a doctor about whether Abilify is right for you and can be taken alongside any other medications you use.

Looking for a therapist but unsure where to start? Psych Central’s How to Find Mental Health Support resource can help.


Russian Academy of Medical Sciences

DEPRESSION (from hope to certainty).


Oleichik I. V. - Candidate of Medical Sciences, Leading Researcher of the Department for the Study of Endogenous Mental Disorders and Affective States

© 2008, Oleichik I.V.
© 2008, NTsPZ RAMS

The vast experience accumulated by mankind and reflected in many literary works convincingly shows that sadness (sadness, spleen) has always gone side by side with people, being one of the natural human emotions. None of us is immune from failures, illness, breakups, loss of loved ones, financial collapse. Each person can face something inevitable and inevitable, when it seems that life loses its meaning, and despair becomes boundless. However, normally, sadness, sadness and melancholy, as natural reactions to traumatic events, weaken over time and the person's condition returns to normal without special treatment. The situation is different with depressions, which are mental disorders that differ from natural physiological reactions in greater intensity, special severity of experiences and persistence of manifestations. True depression rarely goes away on its own, requiring persistent, sometimes long-term treatment.
A depressive state (from the Latin word depressio - suppression, oppression) is a disease that concerns not only an individual specific sick person, but is also a significant burden of modern society, since it is spreading more and more widely in the world, causing enormous damage to the health of the population and the state. economy. And this applies to all countries, regardless of their level of social development. Every year, at least 200 million people in the world fall ill with depression. Perhaps these figures are even higher, since most victims of depression do not seek help, because they are not aware of the painfulness of their condition. Scientists have calculated that almost one in five people who have reached adulthood will experience at least one episode of depression during their lifetime.
In the most general sense, a depressive state is one of the possible forms of a person's response to the impact of stress factors. In some cases, depression can be triggered by external negative influences, for example, mental trauma, excessive educational or work overload, infection or other serious somatic disease, traumatic brain injury, changes in the hormonal background, which is especially important for the female body, regular certain medications, such as hormones, blood pressure medications, alcohol or other drug abuse. In other cases, depressive states develop as a manifestation of such mental illnesses, in which the main influence is heredity or characteristics of the nervous system (cyclothymia, dysthymia, manic-depressive psychosis, schizophrenia, etc.). If, based on the description of depressive symptoms set out later in our brochure, you realize that you have indeed developed a depressive state, do not fall into despair, do not “try to control yourself”, remember that depression is not a manifestation of weakness of will or character, on the contrary, weakening of volitional qualities is one of the main symptoms of depression. Depression is a disease like rheumatism, arthritis or hypertension, it responds well to treatment, resulting in almost always a full recovery. You should not blame yourself for the occurrence of depression, it does not indicate either your fault, or your weakness, or the possible development of a more severe mental pathology. Below we will tell you about the symptoms of depression, which can be extremely diverse.

Manifestations of depression

Manifestations of depression can be very different. Depressive states can be manifested by a violation of almost all aspects of mental life: mood, memory, will, activity, which is expressed in the appearance of sadness, sadness, mental and muscle retardation, lasting at least 2 weeks. Depressed mood during depression can manifest itself as mild sadness, sadness, and boundless despair. Often it is accompanied by a feeling of melancholy, unbearable heaviness in the soul, with excruciating pain behind the sternum, a feeling of hopelessness, deep depression, hopelessness, helplessness, despair and uncertainty. At the same time, the patient is completely immersed in his gloomy experiences, and external events, even the most joyful ones, do not affect him, do not affect his mood, and sometimes even worsen the latter. A constant "companion" of a depressive mood is also anxiety of varying severity: from mild anxiety or tension to violent excitement, riot. Anxiety and bad mood arise at the mere thought of the need to make some kind of decision or change your plans due to suddenly changed circumstances. Anxiety can also manifest itself on the physical (bodily) level in the form of belching, intestinal cramps, loose stools, frequent urination, shortness of breath, palpitations, headaches, increased sweating, etc.
The picture of depression is complemented by the disappearance of desires, interests, a pessimistic assessment of everything around, ideas of one's own low value and self-blame. Deficiency of vital impulses is manifested in patients with a variety of symptoms - from lethargy, physical weakness to a state of weakness, loss of energy and complete impotence. Where an important decision is required, a choice between different options, human activity is sharply hampered. Depressed people are well aware of this: they complain that insignificant everyday tasks, small issues that used to be solved almost automatically, take on the significance of complex, painful, insoluble problems. At the same time, a person feels that he began to think, act and speak slowly, notes the suppression of instincts (including food and sexual instincts), the suppression or loss of the instinct of self-preservation and the lack of the ability to enjoy life up to complete indifference to what used to be liked evoked positive emotions.
People suffering from depression often feel "stupid", "mentally retarded", "feeble-minded". Thinking in depression becomes viscous, painful, requires special efforts, one mental image is hardly forced out by the next. The sick person is oppressed by the feeling of his own intellectual insolvency, professional collapse. Depressed patients can hardly describe their painful experiences to the doctor. Only after getting out of depression, many of them say that the mood at that moment was lowered, thinking was slow, all undertakings (including treatment) seemed in vain, and the years lived were empty and useless. However, at the time of the first visit to the doctor, they could not explain this because of the almost complete absence of thoughts in their heads, “para-lich of thinking”. With depression, there are also often complaints of memory loss, which is why those suffering from it assume that they have "Alzheimer's disease", "schizophrenia", "senile dementia", which is not true. Especially often these complaints are found in depressions that develop in adolescence.
Typical story
Aleksey, 18 years old, 1st year student of a technical university, describes his condition during depression as follows:
“From childhood, I was fond of technology and modeling, I could read special literature for hours, won school and regional olympiads in mathematics and physics. After graduating from school, my dream came true - I brilliantly passed the exams to a prestigious university. Then it seemed to me that the whole world was at my feet, I flew with happiness "as if on wings." In September, I happily began to study. At the beginning, everything worked out well, but after 2 months I began to notice that it was becoming increasingly difficult for me to absorb what I read, I did not remember the simplest text, I could not solve problems that I used to “click like nuts”. Trying to achieve success through many hours of brainstorming or drinking a few cups of coffee led to the fact that I completely stopped thinking about anything. It seemed to me that I was "finally and irreversibly stupid." At night I sobbed, wrapped in a blanket and thought about how best to commit suicide. Luckily, I met a senior in the library and shared my problems with him. My new acquaintance said that he experienced something similar and advised me to contact the psychiatrist of the student clinic. After the examination, I was diagnosed with juvenile depression and sent for treatment to a specialized medical center. After 2 months, I felt completely healthy, returned to my studies and caught up with my classmates.

Depression can also be accompanied by real setbacks: for example, a decrease in academic performance, the quality of work, family conflicts, sexual disorders and their consequences for personal relationships. As a rule, the significance of these failures is exaggerated and as a result there is a false sense of the irreparability of what happened, "the collapse of all hopes."
Another generally recognized danger of depression is the possibility of suicidal thoughts, which often lead to suicide attempts. The condition of a person suffering from depression can suddenly deteriorate sharply, which happens either without clear external causes, or under the influence of traumatic situations, unpleasant news. It is during these hours, and sometimes even minutes, that a fatal decision is made. Factors that increase the risk of suicide in depression are past suicide attempts, the severity and duration of the depressive state, the presence of anxiety in its structure, prolonged insomnia, loneliness or alienation in the family, alcohol and drug abuse, loss of work and a sharp change in lifestyle, as well as relatives commit suicide.
Typical story
Eugene E., 35 years old, leading manager of the company.
Almost all my life, my career went “on the ascending”, the goals set were clear, clear and achievable. The marriage was extremely harmonious, two beloved children grew up. He devoted almost all the time to the affairs of the company, occasionally, once every 1-2 months, he escaped with his family out of town, to the country. He often lacked sleep, stayed late at work, took home assignments, and was deeply worried about the affairs of the company. Gradually, irritability, fatigue, insomnia, difficulty concentrating appeared, more and more often he suffered a “fiasco” in intimate life. Thoughts appeared that life was lived in vain, that it is a "chain of tragic mistakes" that led to a dead end. He began to believe that the choice of work, friends, family was wrong, for which now "retribution has come." Analyzing the past years for a long time, he found more and more evidence and examples of his "duplicity, hypocrisy, insincerity, etc. " I realized that the only way to solve all problems is to voluntarily leave this life. At the same time, he believed that by this act he would free the family from the “burden”, “loser”, “loser”. I decided, having locked myself in the garage, to get poisoned by the exhaust gases of the car. However, by chance, in a semi-conscious state, he was discovered by an employee of a garage cooperative. He explained what happened as an "accident". The thought of leaving life did not leave the patient. I decided to shoot myself with a gas pistol, which I had long ago acquired for self-defense. After a shot in the mouth, in a serious condition, he was taken to the Research Institute. Sklifasovsky, from where he was discharged a week later. The alarmed wife, suspecting something was wrong, decided to consult her husband with a psychiatrist. He was admitted to the clinic. He agreed to this only out of respect for family relations, he himself believed that treatment by psychiatrists was completely useless, because. his situation is hopeless and no medicines will help here, but will only "stupefy" his psyche. However, after two weeks of taking a modern antidepressant, the patient's point of view changed. Everything began to look not so bleak and hopeless, interest in work and life in general returned, I began to feel more cheerful, more energetic, interest in intimate life appeared. He took work to the clinic, called up colleagues. After two months of treatment, he fully returned to his usual life. With bewilderment, he recalled his thoughts about insolvency, the collapse of life, suicide. He took the drug prophylactically for about six months, then, on the recommendation of a doctor, he gradually reduced the dose and stopped taking it. Over the next two years, the condition remained stable, career growth continued, another child was born.

Depression is also characterized by sleep disturbances, occurring in approximately 80% of patients. As a rule, these are early awakenings with the inability to fall asleep, lack of a sense of sleep, difficulty falling asleep. These disorders, as well as restless sleep with unpleasant dreams, are often the very first symptoms of incipient depression.
If the depression is not deep, it is sometimes difficult to recognize it. This is due to the fact that people are ashamed to tell others about their problems, to admit to "weaknesses". Quite often, especially in Russia, depressive states are masked by alcohol abuse (“vodka heals”). In addition, often patients suffering from depression, in order to "shake themselves up", "throw into all serious", engage in casual sex, are fond of gambling or extreme sports, leave to serve on a contract in "hot spots", lead an idle lifestyle with constant attendance at entertainment events. Surrounding people, relatives who do not have psychiatric knowledge, often accuse them of debauchery, drunkenness, riotous lifestyle, parasitism. Meanwhile, this behavior is a kind of “cry for help”, an attempt to fill the spiritual emptiness brought by depression with new acquaintances and impressions.
Depressive conditions can occur in shallow forms that are easily treatable, but at least a third of depressions are more severe. Such depressions are characterized by:
- ideas of guilt, sometimes reaching the degree of delirium, i.e. unshakable conviction in their sinfulness, low value (patients consider themselves great sinners, believe that because of them all relatives and Mankind will die, that they are “moral freaks” from birth, supposedly deprived of the foundations of morality and a sense of empathy for other people that they have no place on earth They find in their past numerous "confirmations" of what has been said above, they believe that the doctor and other patients are aware of these transgressions and express contempt and indignation with their facial expressions and gestures, but in the words “they hide, deny the obvious.” Both the patients themselves and their relatives must remember this in order to prevent the impending threat in time: remove all firearms, piercing and cutting objects, ropes, potent drugs and poisonous close household fluids, close windows or shutters, do not let the patient go anywhere alone. If these ideas become persistent and cannot be dissuaded, it is urgent to seek advice from a psychiatrist. neurological institution or call a psychiatrist at home.
- mood swings during the day: in typical cases, the patient, waking up, immediately feels longing. Sometimes, even before full awakening, through a dream he experiences a painful premonition of a heavy coming morning. In the evening, the state of health improves somewhat.
- the patient may experience a feeling of unmotivated hostility towards relatives, friends, constant internal discontent and irritation, which makes him unbearable for the family.
- in a number of people suffering from depression, constant doubts, fear for the health and well-being of loved ones, obsessive ones, come to the fore. arising against the will, ideas about the misfortunes and troubles of family members.

Typical story
Dmitry Petrovich, 58 years old, teacher.
“After minor troubles at work, I began to feel incomprehensible anxiety and agitation. Unpleasant thoughts came into my head that I did something wrong at work, because of which I double-checked everything many times and went home later than everyone else. But even at home, the anxiety did not let go: as soon as the daughter or wife lingered for at least half an hour, terrible pictures of traffic accidents or violence were drawn in the imagination. I fell asleep only in the morning, got up broken and felt sleepy all day. I took Valerian, Corvalol, but it practically did not help. At work, they hinted whether I should take a vacation. Friends advised me to consult a neuropathologist, but he did not find his pathology and sent me to a psychiatrist. I was diagnosed with anxiety depression. After a course of outpatient treatment, I completely recovered.”

- in many cases, depression is characterized by unpleasant sensations in the body, disturbances in the activity of internal organs in the absence of objective signs of true somatic, i.e. non-mental illness. At the same time, many patients constantly report pain, internal discomfort. Some complain of headaches, pains in the stomach, joints, lower back, others - of disorders in the intestines: constipation, indigestion, irritation of the colon, others pay attention to a decrease in sexual desire and potency. In women, menstruation often becomes painful and irregular. Approximately 50% of depressed people at the doctor's office complain of such physical ailments, without mentioning the depressed mood or state of mind underlying the depression. Experiencing chronic pain or other unpleasant sensations in the body, patients may not realize that they are suffering from depression, even with severe melancholy, considering the latter a reaction to painful bodily discomfort.
- some patients are convinced that they have some rare and difficult to diagnose disease and insist on numerous examinations in general medical institutions. Doctors call this condition masked (hidden) depression, in which a person may experience pain in the head, in the limbs, behind the sternum, in the abdomen and in any other parts of the body, he may be haunted by anxious fears, he may suffer from insomnia or, on the contrary, too much sleep.
- Patients may experience disturbances in the cardiovascular system, skin itching or lack of appetite. All of these are manifestations of depression.
- the pathological sensations that patients experience during such depressions are quite real, painful, but they are the result of a special mental state, and not an internal disease. It must be remembered that the frequency of latent depressions exceeds the number of explicit ones many times over.
- with such depression, patients, as a rule, also have a changed attitude towards food: they can go without food for a long time and not feel hungry, and sitting down at the table, eat only 1-2 spoons - they have neither strength nor desire for more .
- a sign of depression can serve as a weight loss of more than 5 kg. within a month. In some people, especially women, the appetite for depression, on the contrary, increases, sometimes reaching the level of excruciating hunger, accompanied by severe weakness and pain in the epigastric region. In some cases, food is taken in excess due to an increased craving for sweets or attempts to distract oneself from painful thoughts by frequent eating.
Thus, we see that depression is a disease with many different manifestations that do not go away on their own, requiring special, sometimes long-term, medical intervention. Therefore, when the symptoms described above appear, it is necessary to seek help from a psychiatrist who will prescribe and monitor antidepressant treatment.


To date, it can be argued that the vast majority of cases of depression respond well to treatment. According to modern views, effective treatment of depression consists of a combination of pharmacotherapy, psychotherapy and, if necessary, other types of treatment. At the same time, the main role in therapy, of course, belongs to antidepressants - drugs specially designed for the treatment of various types of depression.
The creation of antidepressants is based on the discovery of scientists that depression develops as a result of a violation of the mechanism of biochemical transmission of nerve impulses in the brain regions responsible for mood, behavior, response to stress, sleep and wakefulness, appetite and some other functions. To ensure the coordination of the work of all these functional divisions, the brain sends special "commands" to them in the form of chemical impulses transmitted from the processes of one nerve cell (neuron) to the processes of another. This transmission is carried out with the help of chemical mediators (neurotransmitters), which, after transmitting a signal, partially return to the original neuron. This process is called neurotransmitter reuptake. Thanks to him, the number of mediators in the microscopic space between the processes of neurons (in the so-called synaptic cleft) decreases, which means that the necessary signals are transmitted worse. Numerous studies have shown that mediators of various structures, in particular, norepinephrine and serotonin, are involved in the transmission of signals that ensure the normal functioning of the nervous system. The first of them has a general activating effect, maintains the level of wakefulness of the body and takes part in the formation of adaptive reactions, and the second has the main antidepressant effect, controls impulsive actions, anxiety, aggressiveness, sexual behavior, falling asleep, feeling of pain, therefore serotonin is called sometimes a "good mood" regulator. A decrease in the number of mediators in the synaptic cleft causes symptoms of depression, while an increase, on the contrary, prevents their appearance. The ability of some drugs in one way or another to increase the concentration of mediators in the synaptic cleft allows them to be used as antidepressants.
Now antidepressants are used in Russia, which can be conditionally divided into 4 generations according to the time of creation.
The first antidepressants to find wide clinical use were tricyclic drugs: amitriptyline and imipramine. They have a fairly powerful effect on most depressive states by blocking the reuptake of both norepinephrine and serotonin. However, the real clinical effect of these drugs is significantly offset by their undesirable side effects, which drastically reduce the quality of life of patients during treatment. Side effects of tricyclic antidepressants arise due to the nonspecificity of their effect on receptor structures. Acting in addition to the serotonin and norepinephrine system and other neurotransmitters (acetylcholine, histamine, dopamine), these antidepressants cause side effects such as urinary retention, dry mucous membranes, constipation, palpitations, fluctuations in blood pressure, confusion, tremor, sexual dysfunction. functions, weight gain. In such cases, it is necessary to prescribe other drugs to correct side effects or reduce the therapeutic dose of drugs, which naturally affects the effectiveness of the antidepressant action. It has been observed that up to 50% of patients refuse to take tricyclic antidepressants due to severe side effects. For the same reason, physicians are less likely to prescribe these drugs to patients on an outpatient basis.
The situation was somewhat improved by the introduction into practice of drugs of the second generation - tetracyclic antidepressants, which, along with the ability to block the reuptake of norepinephrine and serotonin, could also affect some other receptors. Being analogues of tricyclic compounds, these drugs have antidepressant activity comparable to them, but unlike their predecessors, they are safer, since they cause unwanted side effects much less often. In addition to the antidepressant, mianserin (lerivon) has a clear sedative, anti-anxiety and hypnotic effect. Maprotiline (Ludiamil) has a mild balanced antidepressant effect. In general, these drugs are able to cure mild to moderate depression, but are ineffective in patients with severe depression.
To date, antidepressants of the 3rd generation, such as fluoxetine (Prozac), fluvoxamine (Fevarin), paroxetine (Paxil), sertraline (Zoloft), citalopram (Cipralex) and some other drugs that selectively (selectively) affect the serotonin metabolism system, have received widespread recognition today. , preventing its reuptake in the synaptic cleft. Based on the mechanism of action, these antidepressants are combined into a group of selective serotonin reuptake inhibitors. In addition to treating depression, they are used to correct eating disorders, level panic disorders, so-called social phobias, various obsessive-compulsive disorders and chronic pain symptoms. These drugs have gained popularity due to the possibility of a once-daily intake, concomitant anti-anxiety effect, the presence of a psychostimulant component and a small number of side effects. In addition, they have low toxicity and are well tolerated by elderly patients. However, some researchers note their lack of effectiveness in the treatment of severe forms of depressive states, probably associated with selective activity in relation to only one neurotransmitter - serotonin. It should be noted that in recent years, some American scientists have associated the use of these drugs with an increased risk of suicide, which, however, is not proven.
Considering the high frequency of side effects in some of the above drugs and the insufficient antidepressant activity in others, psychopharmacologists have taken the path of developing more effective antidepressants - IV generation drugs that selectively block the reuptake of both serotonin and noradrenaline, without affecting other mediators. system and with minor side effects. Currently, 3 drugs meet these requirements: milnacipran (Ixel), duloxetine (Cymbalta) and venlafaxine (Effexor). Their antidepressant activity in the treatment of patients with severe and moderate depression has been confirmed in a number of specially conducted studies, which at the same time showed that these drugs are well tolerated.
It should be noted that antidepressants of plant origin (negrustin, gelarium hypericum, deprim, etc.) can be effective in mild depressive states, but there are no reliable data guaranteeing their effectiveness. The opinion of a number of doctors that all depression can be treated with herbs or, say, acupuncture, should be recognized as unfounded.
For extremely severe depressions that do not improve despite the use of the most powerful antidepressants, electroconvulsive therapy (ECT) can be effective, but this situation is extremely rare and requires careful justification by the commission of doctors and the consent of the patient.
An important additional role in antidepressant therapy, especially with concomitant anxiety, is played by tranquilizers - anti-anxiety drugs, such as Xanax, phenazepam, diazepam, nitrazepam, atarax, etc. Drugs that can, when taken systematically, prevent mood swings in various depressive disorders include so-called mood stabilizers or mood stabilizers - lithium preparations, carbamazepine, valproic acid salts, lamotrigine, topiramate. With their systematic intake in most patients, the clinical manifestations of depression either completely disappear or become rare and mild, requiring no hospitalization and not significantly affecting the ability to work.
Antipsychotics play a significant role in the treatment of certain forms of depression. These include both traditional drugs - fluanxol, triftazin, eglonil, teralen, neuleptil, sonapax, and atypical antipsychotics that are gaining more and more recognition among doctors: seroquel, solian, zeldox, rispolept, abilify, serdolect and others.
In drug therapy of depressive conditions, an unconventional, strictly individual approach is used, with the obligatory provision of fruitful cooperation between the patient and the doctor. Otherwise, there may be a violation of medical recommendations regarding doses and regimens for taking medications. The patient's faith in the possibility of recovery, the absence of prejudice against the "harm" caused by psychotropic drugs, the systematic observance of the prescriptions prescribed by the doctor largely contribute to the achievement of therapeutic success.
Drug treatment of depression takes time. You should not expect a complete cure already in the first days of taking the drug. It must be remembered that all modern antidepressants begin to act on depressive symptoms no earlier than 1-2 weeks after the start of treatment. Cancellation of an antidepressant, as well as its appointment, should be carried out only by a doctor. Cancellation is usually made no earlier than 6 months from the normalization of the mental state. Even after the complete disappearance of all symptoms of depression, do not rush to stop taking the drug yourself, as there is a risk of an exacerbation of the disease. Therefore, doctors recommend continuing to take the antidepressant for a certain period of time. A common mistake is the premature withdrawal of drugs soon after a significant improvement in the condition or due to "forgetfulness". To avoid this, try to include the drug in the list of daily urgent matters - for example, store it in the bathroom and take it after hygiene procedures. When planning a trip, calculate exactly how many tablets you need for the entire period of absence from home. Breaking therapy is fraught with serious troubles.
Conducted along with drug treatment, psychotherapy of patients with depressive states implies various systems of influence, including individual conversations, family and group therapy, etc. An important element of social rehabilitation is participation in the work of mutual support groups for patients who have experienced depression. This allows other patients to feel help in understanding their problems, to realize that they are not alone in their misfortune, to see the possibilities of personal participation in rehabilitation activities and in public life.

Vasechkin Viktor Borisovich - 4 reviews | Moscow

4 reviews

from 5000 ₽

Psychiatrnarcologistpsychotherapist4 review

Experience 35 years

Highest category


Documents verified

Vasechkin Viktor Borisovich, Moscow: psychiatrist, narcologist, psychotherapist, 4 patient reviews, places of work, candidate of sciences, the highest category, experience 35 years, an appointment ☎ (499) 110-11-34.

Thank you

A review is not the only way to say “Thank you” to a doctor. You can transfer money to the doctor's personal account.

Updated 09/16/2022

Report the error


Treatment Profile










Basic education

  • 1988

    Chisinau State Medical Institute (Psychiatry)


  • 1999

    Russian Medical Academy of Postgraduate Education (RMAPO) (psychiatry-narcology)

    Retraining cycles

  • 2003

    Russian Medical Academy of Postgraduate Education (RMAPO) (psychotherapy)

    Retraining cycles

  • Rating


    Popular rating +6. 5

    Examination +2.0

    Effectiveness of treatment +2.0

    Attitude towards the patient +2.0

    Information +2.0

    Would you recommend a doctor? +2.0

    Experience35 years


    PhD degree



    September 16 at 15:14

    +2.0 Great

    Thorough examination

    Attitude towards the patient

    Informing the patient

    Would you recommend a doctor?





    verified (2)

    Visited in September 2022

    "Coisino Medical Center" (previously Medical Center "Vanclinik")-Simferopolsky B. , 10, building . 1


    September 5 at 19:09

    +2.0 Great

    Examination thoroughness

    Effectiveness of treatment

    Attitude towards the patient

    Informing the patient

    Would you recommend a doctor?






    were verified (3)

    Visited in September 2022

    "Coisino in Zyuzino" (previously Medical Center "Vanclinik")-RP Simferopol, village. 10, bldg. 1


    December 26, 2018
    at 12:09

    +2.0 excellent

    Checked (1)

    Vatutina, 1


    September 16, 2018
    at 10:30


    Learn more